Related content

Genetic polymorphisms of human flavin-containing monooxygenase 3: implications for drug metabolism and clinical perspectives

By Hisamuddin Irfan M   Yang Vincent W  

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 635-643

Future Medicine

Access to resources Recommend Favorite

Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism

By Cashman John R  

Pharmacogenomics, Vol. 3, Iss. 3, 2002-05 ,pp. : 325-339

Future Medicine

Access to resources Recommend Favorite

Human Flavin-Containing Monooxygenase Substrate Specificity and Role in Drug Metabolism

By  

Current Drug Metabolism, Vol. 1, Iss. 2, 2000-09 ,pp. : 181-191

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Flavin-Containing Monooxygenase (FMO) in the Metabolism of Tamoxifen and Other Tertiary Amines

By Krueger Sharon   VanDyke Jonathan   Williams David   Hines Ronald  

Drug Metabolism Reviews, Vol. 38, Iss. 1-2, 2006-05 ,pp. : 139-147

Informa Healthcare

Access to resources Recommend Favorite

Genetic Polymorphism of the Flavin-Containing Monooxygenase 3 (FMO3) Associated with Trimethylaminuria (Fish Odor Syndrome): Observations from Japanese Patients

By  

Current Drug Metabolism, Vol. 8, Iss. 5, 2007-06 ,pp. : 487-491

Bentham Science Publishers

Access to resources Recommend Favorite